Health and Happiness (H&H) International Holdings Limited (abbreviated as H&H) has issued a notice convening its 2026 Annual General Meeting (AGM) for 15 May 2026 at 9:30 a.m. in Central, Hong Kong.

Key resolutions to be tabled:

1. FY25 Results & Dividend • Shareholders will vote on adopting the audited consolidated financial statements for the year ended 31 December 2025. • The Board recommends a final dividend of HK$0.16 per ordinary share, to be funded from retained profits. • The share register will be closed from 21 May 2026 to 26 May 2026 (both days inclusive). The record date for dividend entitlement is 26 May 2026.

2. Board Composition & Remuneration • Re-election of three directors: non-executive director Mrs Laetitia Albertini and independent non-executive directors Mrs Lok Lau Yin Ching and Professor Ding Yuan. • Authorisation for the Board to determine directors’ remuneration.

3. Auditor Re-appointment • Proposal to re-appoint Ernst & Young as external auditor for the next financial year and authorise the Board to fix its remuneration.

4. Capital Management Mandates • General mandate permitting the Board to issue and deal with new shares—up to 20% of the Company’s issued share capital (excluding treasury shares) at the date of the AGM. • Share buy-back mandate allowing repurchase of up to 10% of the issued share capital. • An extension mandate to increase the share-issue limit by the number of shares actually repurchased, capped at an additional 10%.

5. Meeting Logistics • The share register will be closed from 12 May 2026 to 15 May 2026 for determining AGM voting eligibility; the record date is 15 May 2026. • All resolutions will be decided by poll, with results published on the Hong Kong Exchanges and Clearing Limited (HKEX) website. • Proxy forms must be lodged with Computershare Hong Kong Investor Services Limited no later than 9:30 a.m. on 13 May 2026.

As at the notice date, H&H’s Board comprises two executive directors (Mr Luo Fei and Mr Wang Yidong), four non-executive directors and three independent non-executive directors.